Dáil Éireann Debate, Tuesday - 14 June 2016
440. Deputy Gerry Adams asked the Minister for Health further to Parliamentary Question No. 100 of 2 June 2016, the types of cancer that are suitable for treatment using the combined nivolumab-ipilimumab therapy; if he will provide this combined therapy to suitable cancer sufferers; and if he will make a statement on the matter. [15720/16]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013.
As these are operational and clinical matters, I have asked the HSE to respond to you directly. If you have not received a reply from the HSE within 15 working days, please contact my Private Office and my officials will follow the matter up.
